Stay updated on Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:20:41.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:34:36.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and an older site-wide funding-status notice, along with Revision: v3.4.1, were removed; there are no changes to core study data, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:09:33.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page now displays a government funding status notice and an update to the revision (v3.4.1); these are informational and do not affect the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:21:49.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Show glossary added and footer items updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. These changes are formatting and versioning updates rather than changes to the study data.
    Difference
    0.2%
    Check dated 2026-01-28T06:16:09.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    This is a minor revision update: Revision v3.3.4 was added and v3.3.3 removed, with no impact on core study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:45:29.000Z thumbnail image

Stay in the know with updates to Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial page.